Medtronic Neuromodulation has recalled 7,123 units of the Vanta Clinician Programmer Application (CP App) versions 2.0.2465 and 2.0.2683. This software is used on Samsung tablets (CFN CT900) to program Vanta Neurostimulators during medical procedures. The app may not function as intended, which could lead to surgical delays or the postponement of operations. The implanted neurostimulator devices themselves are not affected and continue to function normally.
The software malfunction can cause the application to fail during use, potentially leading to prolonged or postponed surgical procedures. While no specific patient injuries were reported, surgical delays can increase the time a patient is under anesthesia or require additional operations.
Software is deployed and operated on Samsung tablets (CFN CT900). Implanted Vanta Neurostimulator devices are not affected.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.